跳至主要内容
临床试验/NCT02128178
NCT02128178Unknown1 期

Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study

Mansoura University1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2013年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
700
试验地点
1
主要终点
Venous thrombosis and/or pulmonary embolism (PE)

研究概览

简要总结

Obese patients undergoing bariatric surgery warrant VTE prophylaxis because they are at high risk for developing a fatal pulmonary embolism or postthrombotic syndrome. However, a consensus does not exist on the most effective prophylactic approach.

详细描述

Two regimens of prophylaxis are supposed , the 1st one is to give enoxaparin 40mg 2 hours before surgery and continued daily for 10 days after, and the 2nd one is to start 12 hours before surgery and continued in the same way like the 1st one.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • BMI >40 OR >35 with comorbidities

排除标准

  • 未提供

研究组 & 干预措施

ENOXAPARIN 2 HOURS BEFORE

Active Comparator

Giving 40 mg enoxaparin SQ 2 hours before surgery and daily for 10 days thereafter

干预措施: Enoxaparin 40 mg 2 hours before arm (Drug)

ENOXAPARIN 2 HOURS BEFORE

Active Comparator

Giving 40 mg enoxaparin SQ 2 hours before surgery and daily for 10 days thereafter

干预措施: Enoxaparin 40 mg 12 hours before arm (Drug)

Enoxaparin 40 mg 12 hours before

Active Comparator

Enoxaparin 40 mg 12 hours before surgery and once daily for 10 days thereafter

干预措施: Enoxaparin 40 mg 2 hours before arm (Drug)

Enoxaparin 40 mg 12 hours before

Active Comparator

Enoxaparin 40 mg 12 hours before surgery and once daily for 10 days thereafter

干预措施: Enoxaparin 40 mg 12 hours before arm (Drug)

结局指标

主要结局

Venous thrombosis and/or pulmonary embolism (PE)

时间窗: Postoperative 4 weeks

To assess the venous thrombosis by compression ultrasonography and PE in suspected patients

次要结局

  • hospital stay(4 WEEKS)
  • Bleeding from the surgery site , drain if any, GIT bleeding,(postoperative 4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

MOHAMED ABDELLATIF

phd

Mansoura University

研究点 (1)

Loading locations...

相似试验